REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/01/2026
Voltar para busca
Dado oficial do USPTO
CANNPAL ANIMAL THERAPEUTICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
06/01/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 31
Data de depósito
15/10/2018
Data de registro
05/01/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/01/2021
Última transação
06/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
11
Localização do titular
AU
Examinador
HUSSAIN,TASNEEM
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of a design of a molecular structure comprising five hexagons attached by four lines. To the right of the design element is the wording "CANNPAL ANIMAL THERAPEUTICS".
Titulares e representantes
Titulares
CannPal Animal Therapeutics Limited
Representantes
Lisa A. Dunner Dunner Law PLLC
Classificação técnica
Classes Nice
Classe 5Classe 31
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Animal care preparations for veterinary usepreparations for supporting joint healthpreparations for supporting skin healthpreparations for supporting immune system health; plant compounds for use as dietary supplements for veterinary purposes; veterinary productspreparations for supporting joint healthpreparations for supporting skin healthpreparations for supporting immune system health; medicated additivesnutritional supplements for animal food; medicated nutritional additivesnutritional supplements and probiotic supplements for animal foodstuffs; protein preparationsnutritional supplements for use as additives to animal foodstuffs for veterinary purposes; all of the foregoing containing hemp seed oil and no CBD or THC
Classe 31
Pet food; pelleted pet food; powdered pet food; pet foodedible chews for animals; all of the foregoing containing hemp seed oil and no CBD or THC
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
02/05/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
08/04/2021
FIMP
FINAL DISPOSITION PROCESSED
08/04/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/01/2021
GPNX
NOTIFICATION PROCESSED BY IB
24/10/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/10/2020
PUBO
PUBLISHED FOR OPPOSITION
20/10/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/09/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/09/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
08/09/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/09/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
08/09/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/09/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
29/05/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/05/2020
GNFR
FINAL REFUSAL E-MAILED
11/05/2020
CNFR
FINAL REFUSAL WRITTEN
11/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/04/2020
ALIE
ASSIGNED TO LIE
24/04/2020
NREV
NOTICE OF REVIVAL - E-MAILED
22/04/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/04/2020
PETG
PETITION TO REVIVE-GRANTED
21/04/2020
PROA
TEAS PETITION TO REVIVE RECEIVED
21/04/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
15/04/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
15/04/2020
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
01/04/2020
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
01/04/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/03/2020
RFNT
REFUSAL PROCESSED BY IB
04/10/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/09/2019
RFRR
REFUSAL PROCESSED BY MPU
11/09/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
30/08/2019
CNRT
NON-FINAL ACTION WRITTEN
29/08/2019
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
21/08/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
25/07/2019
CNRT
NON-FINAL ACTION WRITTEN
24/07/2019
DOCK
ASSIGNED TO EXAMINER
19/07/2019
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
09/05/2019
DOCK
ASSIGNED TO EXAMINER
06/02/2019
DOCK
ASSIGNED TO EXAMINER
24/01/2019
MAFR
APPLICATION FILING RECEIPT MAILED
23/11/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/11/2018
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
15/11/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CANNPAL ANIMAL THERAPEUTICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.